➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Baxter
Moodys
McKesson
Medtronic
Harvard Business School
Johnson and Johnson

Last Updated: August 4, 2020

DrugPatentWatch Database Preview

Miglitol - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What are the generic drug sources for miglitol and what is the scope of patent protection?

Miglitol is the generic ingredient in two branded drugs marketed by Pharmacia And Upjohn and Orient Pharma Co Ltd, and is included in two NDAs. Additional information is available in the individual branded drug profile pages.

There is one drug master file entry for miglitol. Two suppliers are listed for this compound.

Drug Prices for miglitol

See drug prices for miglitol

Recent Clinical Trials for miglitol

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Drug Safety and Effectiveness Network, CanadaN/A
Canadian Network for Observational Drug Effect Studies, CNODESN/A
Canadian Institutes of Health Research (CIHR)N/A

See all miglitol clinical trials

Pharmacology for miglitol

US Patents and Regulatory Information for miglitol

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Orient Pharma Co Ltd MIGLITOL miglitol TABLET;ORAL 203965-003 Feb 24, 2015 AB RX No No   Start Trial   Start Trial   Start Trial
Orient Pharma Co Ltd MIGLITOL miglitol TABLET;ORAL 203965-002 Feb 24, 2015 AB RX No No   Start Trial   Start Trial   Start Trial
Pharmacia And Upjohn GLYSET miglitol TABLET;ORAL 020682-001 Dec 18, 1996 AB RX Yes Yes   Start Trial   Start Trial   Start Trial
Orient Pharma Co Ltd MIGLITOL miglitol TABLET;ORAL 203965-001 Feb 24, 2015 AB RX No No   Start Trial   Start Trial   Start Trial
Pharmacia And Upjohn GLYSET miglitol TABLET;ORAL 020682-003 Dec 18, 1996 AB RX Yes No   Start Trial   Start Trial   Start Trial
Pharmacia And Upjohn GLYSET miglitol TABLET;ORAL 020682-002 Dec 18, 1996 AB RX Yes No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for miglitol

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pharmacia And Upjohn GLYSET miglitol TABLET;ORAL 020682-001 Dec 18, 1996   Start Trial   Start Trial
Pharmacia And Upjohn GLYSET miglitol TABLET;ORAL 020682-003 Dec 18, 1996   Start Trial   Start Trial
Pharmacia And Upjohn GLYSET miglitol TABLET;ORAL 020682-002 Dec 18, 1996   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Colorcon
Johnson and Johnson
McKinsey
Medtronic
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.